Health Trials

Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis

ConditionsPsoriasisCardiovascular DiseasesCardiovascular Risk FactorCardiovascular PathologyPsoriasis VulgarisPsoriatic NailPsoriasis FacePsoriasis GuttatePsoriasis GyrataPsoriasis DiffusaPsoriasis PalmarisPsoriasis AnnularisPsoriasis CircinataPsoriasis PlantarisPsoriasis UniversalisPsoriasis GeographicaLeft Ventricular DysfunctionMyocardial InfarctionMyocardial IschemiaHeart FailureStrokeHeart DiseasesHeart Failure, SystolicHeart Failure, Diastolic
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHerlev and Gentofte Hospital

About this trial

In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether these are prognostic markers of heart disease in patients suffering from psoriasis.

Eligibility criteria

Qualifiers

Patients 18 years or older with a diagnosis of psoriasis will be invited to participate

Disqualifiers

Patients not able to cooperate to the study

Patients unable understand and sign informed consent

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 2 trial groups

Locations

1
Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen2900, HellerupCopenhagne, Denmark

Sponsors and collaborators

Herlev and Gentofte Hospital

Lead sponsor

Source ClinicalTrials.gov